CAMBRIDGE, Mass., April 13, 2026 (GLOBE NEWSWIRE)-- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results